[1]
Preuss CV, Kalava A, King KC. Prescription of Controlled Substances: Benefits and Risks. StatPearls. 2024 Jan:():
[PubMed PMID: 30726003]
[2]
Paul IM, Reynolds KM, Green JL. Adverse events associated with opioid-containing cough and cold medications in children. Clinical toxicology (Philadelphia, Pa.). 2018 Nov:56(11):1162-1164. doi: 10.1080/15563650.2018.1459665. Epub 2018 Apr 10
[PubMed PMID: 29631464]
[3]
Rosenblum A, Marsch LA, Joseph H, Portenoy RK. Opioids and the treatment of chronic pain: controversies, current status, and future directions. Experimental and clinical psychopharmacology. 2008 Oct:16(5):405-16. doi: 10.1037/a0013628. Epub
[PubMed PMID: 18837637]
Level 3 (low-level) evidence
[4]
Cardia L, Calapai G, Quattrone D, Mondello C, Arcoraci V, Calapai F, Mannucci C, Mondello E. Preclinical and Clinical Pharmacology of Hydrocodone for Chronic Pain: A Mini Review. Frontiers in pharmacology. 2018:9():1122. doi: 10.3389/fphar.2018.01122. Epub 2018 Oct 1
[PubMed PMID: 30327606]
[5]
Galligan JJ, Sternini C. Insights into the Role of Opioid Receptors in the GI Tract: Experimental Evidence and Therapeutic Relevance. Handbook of experimental pharmacology. 2017:239():363-378. doi: 10.1007/164_2016_116. Epub
[PubMed PMID: 28204957]
[6]
Stein C. Opioid Receptors. Annual review of medicine. 2016:67():433-51. doi: 10.1146/annurev-med-062613-093100. Epub 2015 Aug 26
[PubMed PMID: 26332001]
[7]
Winters BL, Gregoriou GC, Kissiwaa SA, Wells OA, Medagoda DI, Hermes SM, Burford NT, Alt A, Aicher SA, Bagley EE. Endogenous opioids regulate moment-to-moment neuronal communication and excitability. Nature communications. 2017 Mar 22:8():14611. doi: 10.1038/ncomms14611. Epub 2017 Mar 22
[PubMed PMID: 28327612]
[8]
Takahama K, Shirasaki T. Central and peripheral mechanisms of narcotic antitussives: codeine-sensitive and -resistant coughs. Cough (London, England). 2007 Jul 9:3():8
[PubMed PMID: 17620111]
[9]
Phillips RS, Cleary DR, Nalwalk JW, Arttamangkul S, Hough LB, Heinricher MM. Pain-facilitating medullary neurons contribute to opioid-induced respiratory depression. Journal of neurophysiology. 2012 Nov:108(9):2393-404. doi: 10.1152/jn.00563.2012. Epub 2012 Sep 5
[PubMed PMID: 22956800]
[10]
Dhillon S. Hydrocodone Bitartrate ER (Hysingla(®) ER): A Review in Chronic Pain. Clinical drug investigation. 2016 Nov:36(11):969-980
[PubMed PMID: 27718163]
[11]
Stauble ME, Moore AW, Langman LJ, Boswell MV, Baumgartner R, McGee S, Metry J, Jortani SA. Hydrocodone in postoperative personalized pain management: pro-drug or drug? Clinica chimica acta; international journal of clinical chemistry. 2014 Feb 15:429():26-9. doi: 10.1016/j.cca.2013.11.015. Epub 2013 Nov 21
[PubMed PMID: 24269714]
[12]
Valtier S, Bebarta VS. Excretion profile of hydrocodone, hydromorphone and norhydrocodone in urine following single dose administration of hydrocodone to healthy volunteers. Journal of analytical toxicology. 2012 Sep:36(7):507-14. doi: 10.1093/jat/bks058. Epub 2012 Jul 10
[PubMed PMID: 22782534]
[14]
Jaeschke H. Acetaminophen: Dose-Dependent Drug Hepatotoxicity and Acute Liver Failure in Patients. Digestive diseases (Basel, Switzerland). 2015:33(4):464-71. doi: 10.1159/000374090. Epub 2015 Jul 6
[PubMed PMID: 26159260]
[15]
Darwish M, Yang R, Tracewell W, Robertson P Jr, Bond M. Effects of Renal Impairment and Hepatic Impairment on the Pharmacokinetics of Hydrocodone After Administration of a Hydrocodone Extended-Release Tablet Formulated With Abuse-Deterrence Technology. Clinical pharmacology in drug development. 2016 Mar:5(2):141-9. doi: 10.1002/cpdd.238. Epub 2016 Jan 19
[PubMed PMID: 27138027]
[16]
Weller AE, Crist RC, Reiner BC, Doyle GA, Berrettini WH. Neonatal Opioid Withdrawal Syndrome (NOWS): A Transgenerational Echo of the Opioid Crisis. Cold Spring Harbor perspectives in medicine. 2021 Mar 1:11(3):. doi: 10.1101/cshperspect.a039669. Epub 2021 Mar 1
[PubMed PMID: 32229609]
Level 3 (low-level) evidence
[17]
American College of Obstetricians and Gynecologists' Committee on Practice Bulletins—Obstetrics. ACOG Practice Bulletin No. 209: Obstetric Analgesia and Anesthesia. Obstetrics and gynecology. 2019 Mar:133(3):e208-e225. doi: 10.1097/AOG.0000000000003132. Epub
[PubMed PMID: 30801474]
[19]
Crews KR, Monte AA, Huddart R, Caudle KE, Kharasch ED, Gaedigk A, Dunnenberger HM, Leeder JS, Callaghan JT, Samer CF, Klein TE, Haidar CE, Van Driest SL, Ruano G, Sangkuhl K, Cavallari LH, Müller DJ, Prows CA, Nagy M, Somogyi AA, Skaar TC. Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy. Clinical pharmacology and therapeutics. 2021 Oct:110(4):888-896. doi: 10.1002/cpt.2149. Epub 2021 Feb 9
[PubMed PMID: 33387367]
[20]
Brandl E, Halford Z, Clark MD, Herndon C. Pharmacogenomics in Pain Management: A Review of Relevant Gene-Drug Associations and Clinical Considerations. The Annals of pharmacotherapy. 2021 Dec:55(12):1486-1501. doi: 10.1177/10600280211003875. Epub 2021 Mar 26
[PubMed PMID: 33771051]
[21]
Ruano G, Kost JA. Fundamental Considerations for Genetically-Guided Pain Management with Opioids Based on CYP2D6 and OPRM1 Polymorphisms. Pain physician. 2018 Nov:21(6):E611-E621
[PubMed PMID: 30508992]
[22]
Steffens C, Sung M, Bastian LA, Edelman EJ, Brackett A, Gunderson CG. The Association Between Prescribed Opioid Receipt and Community-Acquired Pneumonia in Adults: a Systematic Review and Meta-analysis. Journal of general internal medicine. 2020 Nov:35(11):3315-3322. doi: 10.1007/s11606-020-06155-9. Epub 2020 Sep 3
[PubMed PMID: 32885375]
Level 1 (high-level) evidence
[23]
Chen A, Ashburn MA. Cardiac Effects of Opioid Therapy. Pain medicine (Malden, Mass.). 2015 Oct:16 Suppl 1():S27-31. doi: 10.1111/pme.12915. Epub
[PubMed PMID: 26461073]
[24]
Schmelz M. [Opioid-induced pruritus. Mechanisms and treatment regimens]. Der Anaesthesist. 2009 Jan:58(1):61-5. doi: 10.1007/s00101-008-1478-8. Epub
[PubMed PMID: 19132330]
[25]
Mahajan R, Gupta Y, Singh A, Dhiman P, Midha V, Kakkar C, Narang V, Mehta V, Saggar K, Sood A. Clinical profile and outcomes of opioid abuse gastroenteropathy: an underdiagnosed disease entity. Intestinal research. 2020 Apr:18(2):238-244. doi: 10.5217/ir.2019.00104. Epub 2020 Feb 25
[PubMed PMID: 32088943]
[26]
Verhamme KM, Sturkenboom MC, Stricker BH, Bosch R. Drug-induced urinary retention: incidence, management and prevention. Drug safety. 2008:31(5):373-88
[PubMed PMID: 18422378]
[27]
Ho T, Vrabec JT, Burton AW. Hydrocodone use and sensorineural hearing loss. Pain physician. 2007 May:10(3):467-72
[PubMed PMID: 17525781]
[28]
Ali ES, Peiris AN. Secondary adrenal insufficiency induced by long-term use of opioid analgesics. Proceedings (Baylor University. Medical Center). 2019 Jul:32(3):417-418. doi: 10.1080/08998280.2019.1600180. Epub 2019 May 21
[PubMed PMID: 31384206]
[29]
Dowell D, Haegerich TM, Chou R. CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016. JAMA. 2016 Apr 19:315(15):1624-45. doi: 10.1001/jama.2016.1464. Epub
[PubMed PMID: 26977696]
[30]
Overholser BR, Foster DR. Opioid pharmacokinetic drug-drug interactions. The American journal of managed care. 2011 Sep:17 Suppl 11():S276-87
[PubMed PMID: 21999760]
[31]
Pinson GM, Beall JW, Kyle JA. A review of warfarin dosing with concurrent acetaminophen therapy. Journal of pharmacy practice. 2013 Oct:26(5):518-21. doi: 10.1177/0897190013488802. Epub 2013 Jun 3
[PubMed PMID: 23736105]
[32]
Madadi P, Hildebrandt D, Gong IY, Schwarz UI, Ciszkowski C, Ross CJ, Sistonen J, Carleton BC, Hayden MR, Lauwers AE, Koren G. Fatal hydrocodone overdose in a child: pharmacogenetics and drug interactions. Pediatrics. 2010 Oct:126(4):e986-9. doi: 10.1542/peds.2009-1907. Epub 2010 Sep 13
[PubMed PMID: 20837591]
[33]
Goettsch WG, Sukel MP, van der Peet DL, van Riemsdijk MM, Herings RM. In-hospital use of opioids increases rate of coded postoperative paralytic ileus. Pharmacoepidemiology and drug safety. 2007 Jun:16(6):668-74
[PubMed PMID: 17072916]
[34]
Wu A, Phan C, Nguyen KC, Quindoy M, Lewis J, Apollonio DE. Trends in hydrocodone combination product exposures reported to California Poison Control System (CPCS) following DEA rescheduling. Clinical toxicology (Philadelphia, Pa.). 2021 Apr:59(4):313-319. doi: 10.1080/15563650.2020.1803350. Epub 2020 Aug 25
[PubMed PMID: 32840386]
[35]
Schultz S, Chamberlain C, Vulcan M, Rana H, Patel B, Alexander JC. Analgesic utilization before and after rescheduling of hydrocodone in a large academic level 1 trauma center. Journal of opioid management. 2016 May-Jun:12(2):119-22. doi: 10.5055/jom.2016.0323. Epub
[PubMed PMID: 27194196]
[36]
Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool. Pain medicine (Malden, Mass.). 2005 Nov-Dec:6(6):432-42
[PubMed PMID: 16336480]
Level 1 (high-level) evidence
[37]
Slovis BH, Riggio JM, Girondo M, Martino C, Babula B, Roke LM, Kairys JC. Reduction in Hospital System Opioid Prescribing for Acute Pain Through Default Prescription Preference Settings: Pre-Post Study. Journal of medical Internet research. 2021 Apr 14:23(4):e24360. doi: 10.2196/24360. Epub 2021 Apr 14
[PubMed PMID: 33851922]
[38]
Grissinger M. Tall man letters are gaining wide acceptance. P & T : a peer-reviewed journal for formulary management. 2012 Mar:37(3):132-48
[PubMed PMID: 22605902]
Level 3 (low-level) evidence
[39]
Parthvi R, Agrawal A, Khanijo S, Tsegaye A, Talwar A. Acute Opiate Overdose: An Update on Management Strategies in Emergency Department and Critical Care Unit. American journal of therapeutics. 2019 May/Jun:26(3):e380-e387. doi: 10.1097/MJT.0000000000000681. Epub
[PubMed PMID: 28952972]
[40]
Fan E, Brodie D, Slutsky AS. Acute Respiratory Distress Syndrome: Advances in Diagnosis and Treatment. JAMA. 2018 Feb 20:319(7):698-710. doi: 10.1001/jama.2017.21907. Epub
[PubMed PMID: 29466596]
Level 3 (low-level) evidence
[41]
Darwish M, Bond M, Ma Y, Tracewell W, Robertson P Jr, Webster LR. Abuse Potential with Oral Route of Administration of a Hydrocodone Extended-Release Tablet Formulated with Abuse-Deterrence Technology in Nondependent, Recreational Opioid Users. Pain medicine (Malden, Mass.). 2017 Jan 1:18(1):61-77. doi: 10.1093/pm/pnw122. Epub
[PubMed PMID: 27330154]
[42]
Black JC, Bau GE, Rosen T, Cepeda MS, Wedin GP, Green JL, Dart RC. Changes in Mortality Involving Extended-Release and Long-Acting Opioids After Implementation of a Risk Evaluation and Mitigation Strategy. Pain medicine (Malden, Mass.). 2020 Jan 1:21(1):92-100. doi: 10.1093/pm/pnz031. Epub
[PubMed PMID: 30877807]
[43]
By the 2019 American Geriatrics Society Beers Criteria® Update Expert Panel. American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults. Journal of the American Geriatrics Society. 2019 Apr:67(4):674-694. doi: 10.1111/jgs.15767. Epub 2019 Jan 29
[PubMed PMID: 30693946]
[44]
Chukwulebe SB, Kim HS, McCarthy DM, Courtney DM, Lank PM, Gravenor SJ, Dresden SM. Potentially Inappropriate Medication Prescriptions for Older Adults with Painful Conditions and Association with Return Emergency Department Visits. Journal of the American Geriatrics Society. 2019 Apr:67(4):719-725. doi: 10.1111/jgs.15722. Epub 2019 Jan 27
[PubMed PMID: 30687938]
[45]
Weldon DR. Differential diagnosis of chronic cough. Allergy and asthma proceedings. 2005 Sep-Oct:26(5):345-51
[PubMed PMID: 16450567]
[46]
Stone EM, Rutkow L, Bicket MC, Barry CL, Alexander GC, McGinty EE. Implementation and enforcement of state opioid prescribing laws. Drug and alcohol dependence. 2020 Aug 1:213():108107. doi: 10.1016/j.drugalcdep.2020.108107. Epub 2020 Jun 11
[PubMed PMID: 32554171]
[47]
Hedberg K, Bui LT, Livingston C, Shields LM, Van Otterloo J. Integrating Public Health and Health Care Strategies to Address the Opioid Epidemic: The Oregon Health Authority's Opioid Initiative. Journal of public health management and practice : JPHMP. 2019 May/Jun:25(3):214-220. doi: 10.1097/PHH.0000000000000849. Epub
[PubMed PMID: 30048336]
[48]
Chou R, Korthuis PT, Weimer M, Bougatsos C, Blazina I, Zakher B, Grusing S, Devine B, McCarty D. Medication-Assisted Treatment Models of Care for Opioid Use Disorder in Primary Care Settings. 2016 Dec:():
[PubMed PMID: 28045474]